GLOCALCURE
LIVE

Serial Number

97788906

Owner

Glocal Lab LLC

Attorney

Zoe Bernstein

First Use Date

Aug 30, 2023

Filing Date

Feb 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GLOCALCURE Trademark

Serial Number: 97788906 • Registration: 7517568

GLOCALCURE is a trademark filed by Glocal Lab LLC on February 9, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Glocal Lab LLC (2 trademarks)

54 Darby
Irvine, CA 92620

Entity Type: 16

Trademark Details

Filing Date

February 9, 2023

Registration Date

September 24, 2024

First Use Anywhere

August 30, 2023

First Use in Commerce

August 30, 2023

Published for Opposition

October 3, 2023

Goods & Services

Dietary Supplements; Topical gels for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Topical creams being medicated skin creams for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Topical serums being medicated skin serums for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Topical toners being medicated skin toners for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Topical medicated fluids for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Medicated serums for the treatments of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Medicated Creams for the treatments of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Medicated Gels for the treatments of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Gels, creams and solutions for dermatological use; Medicated Sun screen

Cosmetics; Non-medicated skin creams; Sun cream; Sun screen

Online retail store services featuring dietary supplements, skin care preparations, cosmetics, medical devices, topical gels, topical serums, topical creams, medicated serums, medicated creams, medicated gels, pessaries, sun screens, topical toners

Pessaries; Medical devices for closing wounds; Medical devices for nonsurgical cosmetic treatment; Medical devices for use in treating or diagnosing dermatological, cosmetological and gynecological conditions; Medical devices, namely, hand-held motorized, vibrating devices used near injection sites for reducing pain during hypodermic needle injections; Light-based medical devices, namely, a light emitting diode (LED) device for increasing the human body's own production of collagen; Medical devices for use in treating or diagnosing dermatological, cosmetological and gynecological conditions with integrated recorded operating system software, sold as a unit; Medical devices for accessing subcutaneous structures of the human body for the purpose of administering medical treatment; Medical devices for use in treating or diagnosing dermatological, cosmetological and gynecological conditions with integrated recorded software for reporting dermatological, cosmetological and gynecological conditions, sold as a unit; Topical preparations, namely, sprays and gels, for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo; medical apparatus, namely, injection devices for subcutaneous preparations for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo; medical apparatus, namely, injection devices for intra epidermal preparations for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo; medical apparatus, namely, injection devices for intradermal preparations for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo; medical apparatus, namely, injection devices for hypodermal preparations for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 20, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 20, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 4, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 4, 2024 AITU
USE AMENDMENT FILED
May 26, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
May 26, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 28, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2023 NWOS
NEW APPLICATION ENTERED
Feb 13, 2023 NWAP